XLNX · Xilinx Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q2 '21 | Q3 '21 | Q1 '21 | Q1 '20 | Q3 '20 | Q2 '20 | Q1 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.01B | $935.77M | $878.61M | $766.53M | $803.40M | $726.67M | - | $723.50M | $833.37M | $849.63M |
| Cost of Revenue | $285.54M | $303.48M | $292.51M | $224.82M | $256.40M | $232.80M | - | $240.02M | $293.11M | $286.77M |
| Gross Profit | $725.52M | $632.29M | $586.10M | $541.72M | $547.00M | $493.87M | - | $483.48M | $540.26M | $562.86M |
| R&D | $287.97M | $253.88M | $247.97M | $219.65M | $235.02M | $210.11M | - | $211.54M | $222.98M | $204.10M |
| SG&A | $125.44M | $126.32M | $124.92M | $113.79M | $136.70M | $105.38M | - | $109.61M | $111.60M | $107.42M |
| Total Operating Expenses | $415.41M | $382.45M | $375.74M | $336.30M | $374.57M | $318.36M | - | $324.07M | $336.74M | $311.93M |
| D&A | - | - | $32.19M | - | - | $31.75M | - | - | - | $23.85M |
| Operating Income | $310.11M | $249.84M | $210.36M | $205.42M | $172.43M | $175.51M | - | $159.41M | $203.52M | $250.94M |
| Interest Expense | $10.28M | $10.28M | $10.28M | $14.23M | $14.23M | $11.66M | - | $9.56M | $9.56M | $10.66M |
| Income Tax | $35.31M | $6.09M | $5.02M | $830.0K | $5.16M | $69.53M | - | $3.83M | ($11.15M) | $21.09M |
| Net Income | $300.06M | $234.54M | $206.34M | $193.82M | $170.97M | $93.84M | - | $162.01M | $226.99M | $241.46M |
| EPS - Basic | $1.21 | $0.95 | $0.84 | $0.79 | $0.70 | $0.39 | - | $0.65 | $0.90 | $0.95 |
| EPS - Diluted | $1.19 | $0.94 | $0.83 | $0.79 | $0.69 | $0.38 | - | $0.64 | $0.89 | $0.94 |
Balance Sheet
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q2 '21 | Q3 '21 | Q1 '21 | Q1 '20 | Q3 '20 | Q2 '20 | Q1 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.94B | $1.68B | $1.44B | $1.17B | $1.13B | $1.78B | $1.78B | $1.29B | $1.60B | $1.59B |
| Accounts Receivable | $439.40M | $405.04M | $233.89M | $285.21M | $269.61M | $305.18M | $273.03M | $253.55M | $335.50M | $305.95M |
| Inventory | $331.07M | $285.57M | $287.04M | $311.08M | $300.11M | $292.21M | $304.34M | $328.21M | $335.26M | $336.76M |
| Accounts Payable | $135.38M | $107.43M | $135.44M | $116.05M | $110.08M | $102.52M | $102.13M | $102.69M | $107.11M | $121.38M |
| Current Assets | $4.53B | $4.19B | $3.99B | $3.75B | $3.97B | $3.66B | $2.91B | $3.13B | $3.26B | $3.59B |
| Total Assets | $6.35B | $6.00B | $5.85B | $5.52B | $5.75B | $5.44B | $4.69B | $4.95B | $5.02B | $4.97B |
| Current Liabilities | $684.48M | $614.19M | $714.90M | $624.55M | $1.11B | $1.05B | $1.09B | $515.88M | $505.83M | $497.11M |
| Long-term Debt | $1.49B | $1.49B | $1.49B | $1.49B | $1.49B | $1.49B | $747.11M | $1.25B | $1.25B | $1.25B |
| Total Liabilities | $2.67B | $2.60B | $2.63B | - | - | - | - | - | - | - |
| Stockholders' Equity | $3.67B | $3.40B | $3.12B | $2.89B | $2.60B | $2.32B | $2.32B | $2.64B | $2.70B | $2.61B |
| Retained Earnings | $2.15B | $1.94B | $1.71B | $1.50B | $1.32B | $1.14B | $1.19B | $1.55B | $1.73B | $1.74B |
Cash Flow
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q2 '21 | Q3 '21 | Q1 '21 | Q1 '20 | Q3 '20 | Q2 '20 | Q1 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $389.90M | - | - | $245.47M | - | - | - | $298.22M |
| Investing Cash Flow | - | - | ($389.25M) | - | - | ($1.38B) | - | - | - | $295.28M |
| Financing Cash Flow | - | - | ($12.26M) | - | - | $585.09M | - | - | - | ($547.96M) |
| CapEx | - | - | $17.19M | - | - | $15.46M | - | - | - | $29.20M |
| Free Cash Flow | - | - | $372.71M | - | - | $230.01M | - | - | - | $269.01M |
Ratios
| Metric | Q3 '22 | Q2 '22 | Q1 '22 | Q2 '21 | Q3 '21 | Q1 '21 | Q1 '20 | Q3 '20 | Q2 '20 | Q1 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 71.8% | 67.6% | 66.7% | 70.7% | 68.1% | 68.0% | - | 66.8% | 64.8% | 66.2% |
| Operating margin | 30.7% | 26.7% | 23.9% | 26.8% | 21.5% | 24.2% | - | 22.0% | 24.4% | 29.5% |
| EBITDA margin | - | - | 27.6% | - | - | 28.5% | - | - | - | 32.3% |
| Net margin | 29.7% | 25.1% | 23.5% | 25.3% | 21.3% | 12.9% | - | 22.4% | 27.2% | 28.4% |
| Free cash flow margin | - | - | 42.4% | - | - | 31.7% | - | - | - | 31.7% |
| FCF / Net income | - | - | 1.81 | - | - | 2.45 | - | - | - | 1.11 |
| R&D / Revenue | 28.5% | 27.1% | 28.2% | 28.7% | 29.3% | 28.9% | - | 29.2% | 26.8% | 24.0% |
| SG&A / Revenue | 12.4% | 13.5% | 14.2% | 14.8% | 17.0% | 14.5% | - | 15.2% | 13.4% | 12.6% |
| Effective tax rate | 10.5% | 2.5% | 2.4% | 0.4% | 2.9% | 42.6% | - | 2.3% | -5.2% | 8.0% |
| Return on assets | 4.7% | 3.9% | 3.5% | 3.5% | 3.0% | 1.7% | - | 3.3% | 4.5% | 4.9% |
| Return on equity | 8.2% | 6.9% | 6.6% | 6.7% | 6.6% | 4.0% | - | 6.1% | 8.4% | 9.2% |
| Return on invested capital | 5.4% | 5.0% | 4.5% | 4.7% | 4.1% | 2.6% | - | 4.0% | 5.2% | 6.0% |
| Liquidity | ||||||||||
| Current ratio | 6.62 | 6.81 | 5.58 | 6.00 | 3.56 | 3.50 | 2.68 | 6.06 | 6.44 | 7.22 |
| Quick ratio | 6.13 | 6.35 | 5.17 | 5.50 | 3.29 | 3.22 | 2.40 | 5.43 | 5.78 | 6.54 |
| Cash ratio | 2.83 | 2.74 | 2.01 | 1.87 | 1.01 | 1.70 | 1.64 | 2.50 | 3.17 | 3.20 |
| Leverage | ||||||||||
| Debt / Equity | 0.41 | 0.44 | 0.48 | 0.52 | 0.57 | 0.64 | 0.32 | 0.47 | 0.46 | 0.48 |
| Debt / Assets | 0.24 | 0.25 | 0.26 | 0.27 | 0.26 | 0.27 | 0.16 | 0.25 | 0.25 | 0.25 |
| Debt / EBITDA | - | - | 6.16 | - | - | 7.20 | - | - | - | 4.53 |
| Interest coverage | 30.2x | 24.3x | 20.5x | 14.4x | 12.1x | 15.1x | - | 16.7x | 21.3x | 23.5x |
| Equity multiplier | 1.73 | 1.77 | 1.88 | 1.91 | 2.21 | 2.35 | 2.03 | 1.87 | 1.86 | 1.90 |
| Liabilities / Assets | 0.42 | 0.43 | 0.45 | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.16 | 0.16 | 0.15 | 0.14 | 0.14 | 0.13 | - | 0.15 | 0.17 | 0.17 |
| Inventory turnover | 0.86 | 1.06 | 1.02 | 0.72 | 0.85 | 0.80 | - | 0.73 | 0.87 | 0.85 |
| Days sales outstanding | 159d | 158d | 97d | 136d | 122d | 153d | - | 128d | 147d | 131d |
| Days inventory outstanding | 423d | 343d | 358d | 505d | 427d | 458d | - | 499d | 417d | 429d |
| Days payable outstanding | 173d | 129d | 169d | 188d | 157d | 161d | - | 156d | 133d | 154d |
| Cash conversion cycle | 409d | 372d | 286d | 452d | 393d | 451d | - | 471d | 431d | 406d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 25.8% | 22.1% | 20.9% | -8.0% | 11.0% | - | - | -9.6% | 11.7% | 24.1% |
| Revenue CAGR (3y) | 8.1% | 7.8% | 1.1% | - | - | 2.0% | - | 4.7% | 10.4% | 13.9% |
| Revenue CAGR (5y) | 9.9% | 8.6% | 7.4% | 5.8% | 6.5% | 4.8% | - | 5.0% | 9.6% | 6.8% |
| Gross profit growth (YoY) | 32.6% | 16.7% | 18.7% | 0.3% | 13.1% | - | - | -12.4% | 5.0% | 17.9% |
| Operating income growth (YoY) | 79.9% | 21.6% | 19.9% | 0.9% | 8.2% | - | - | -38.2% | -12.6% | 16.3% |
| Net income growth (YoY) | 75.5% | 21.0% | 119.9% | -14.6% | 5.5% | - | - | -32.3% | 5.2% | 27.1% |
| EPS growth (YoY) | 72.5% | 19.0% | 118.4% | -11.2% | 7.8% | - | - | -31.2% | 6.0% | 27.0% |
| EPS CAGR (3y) | 8.6% | 3.8% | -4.1% | - | - | -19.9% | - | 133.9% | 11.0% | 15.5% |
| EPS CAGR (5y) | 88.5% | 7.7% | 5.7% | 5.3% | 5.8% | -9.0% | - | 5.5% | 13.1% | 8.7% |
| FCF growth (YoY) | - | - | 62.0% | - | - | - | - | - | - | 79.6% |
| FCF CAGR (5y) | - | - | 15.5% | - | - | -6.3% | - | - | - | 17.3% |
| Book value growth (YoY) | 41.4% | 17.6% | 34.5% | 7.1% | -1.6% | 0.2% | -11.4% | 0.2% | 10.3% | 12.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-04-03.
Geographic
$7.82B totalNon USExcluding Asia Pacific$2.27B · 29.0%
Asia Pacific$1.53B · 19.5%
CN$1.02B · 13.0%
North America$880.11M · 11.2%
US$792.70M · 10.1%
Europe$515.00M · 6.6%
Asia Pacific Other$508.73M · 6.5%
JP$223.31M · 2.9%
North America Other$87.41M · 1.1%
Peer comparison
Same SIC group: Semiconductors & Related Devices
Comparing XILINX INC against the 5 most active filers in the same SIC group.